Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 8, 2014, Pages 1667-1679

  Liu, Zhen ^a,b   Mai, Chunping ^b   Yang, Huiling ^b,c   Zhen, Yan ^b   Yu, Xiaoli ^b   Hua, Shengni ^b   Wu, Qiangyun ^b   Jiang, Qinping ^a   Zhang, Yajie ^a,b   Song, Xin ^b,d   Fang, Weiyi ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

^d KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

CCDC19; Lung cancer; miR 184; PI3K AKT; Tumour suppressor

Indexed keywords

CCDC19 PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN184 MICRORNA, HUMAN; MYC PROTEIN; MYC PROTEIN, HUMAN; PROTEIN; TUMOR MARKER;

ADULT; AGED; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CANCER STAGING; CELL CYCLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MOUSE; NON SMALL CELL LUNG CANCER; NUDE MOUSE; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR CELL CULTURE; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84912561923     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12317     Document Type: Article

References (35)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-917.
2. Hanai JI, Doro N, Seth P, et al. ATP citrate lyase knockdown impacts cancer stem cells in vitro. Cell Death Dis. 2013; 4: e696.
3. Kim HR, Kim DJ, Kang DR, et al. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer. J Clin Oncol. 2013; 31: 731-7.
4. Sagne C, Marcel V, Amadou A, et al. A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects. Cell Death Dis. 2013; 4: e492.
5. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 2002; 21: 6915-35.
6. Li Z, Yao K, Cao Y. Molecular cloning of a novel tissue-specific gene from human nasopharyngeal epithelium. Gene. 1999; 237: 235-40.
7. Liu Z, Li X, He X, et al. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism. Int J Cancer. 2011; 128: 2562-71.
8. Liu Z, Luo W, Zhou Y, et al. Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma. PLoS ONE. 2011; 6: e27887.
9. Aboobaker AA, Tomancak P, Patel N, et al. Drosophila microRNAs exhibit diverse spatial expression patterns during embryonic development. Proc Natl Acad Sci USA. 2005; 102: 18017-22.
10. Weitzel RP, Lesniewski ML, Greco NJ, et al. Reduced methyl-CpG protein binding contributing to miR-184 expression in umbilical cord blood CD4+ T-cells. Leukemia. 2011; 25: 169-72.
11. Gao B, Gao K, Li L, et al. miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC). Biomed Pharmacother. 2014; 68: 143-8.
12. Wong TS, Liu XB, Wong BY, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008; 14: 2588-92.
13. Leng HM, Qian WP, Zhou L, et al. Abnormal expression and significance of MIR-184 in human renal carcinoma. Beijing Da Xue Xue Bao. 2011; 43: 509-13.
14. Foley NH, Bray IM, Tivnan A, et al. MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. Mol Cancer. 2010; 9: 83.
15. Fang ZH, Dong CL, Chen Z, et al. Transcriptional regulation of survivin by c-Myc in BCR/ABL-transformed cells: implications in anti-leukaemic strategy. J Cell Mol Med. 2009; 13: 2039-52.
16. Popescu NC, Zimonjic DB. Chromosomemediated alterations of the MYC gene in human cancer. J Cell Mol Med. 2002; 6: 151-9.
17. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17: 1471-4.
18. Wang Y, Wang W, Wang L, et al. Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-α in human hepatocellular carcinoma cells. J Cell Mol Med. 2012; 16: 496-506.
19. Chang L, Graham PH, Hao J, et al. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis. 2013; 4: e875.
20. Yi YW, Hong W, Kang HJ, et al. Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triplenegative breast cancer cells. J Cell Mol Med. 2013; 17: 648-56.
21. Steiner P, Rudolph B, Müller D, et al. The functions of Myc in cell cycle progression and apoptosis. Prog Cell Cycle Res. 1996; 2: 73-82.
22. Nathalie HV, Chris P, Serge G, et al. High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis. J Cell Mol Med. 2009; 13: 4014-22.
23. Yu X, Zhen Y, Yang H, et al. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. Cell Death Dis. 2013; 4: e634.
24. Walluscheck D, Poehlmann A, Hartig R, et al. ATF2 knockdown reinforces oxidative stress-induced apoptosis in TE7 cancer cells. J Cell Mol Med. 2013; 17: 976-88.
25. Simile MM, De Miglio MR, Muroni MR, et al. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis. 2004; 25: 333-41.
26. Lv C, Hong Y, Miao L, et al. Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway. Cell Death Dis. 2013; 4: e952.
27. Wei M, Wang Z, Yao H, et al. P27(Kip1), regulated by glycogen synthase kinase-3b, results in HMBA-induced differentiation of human gastric cancer cells. BMC Cancer. 2011; 11: 109.
28. Hayslip J, Montero A. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review. Mol Cancer. 2006; 5: 44.
29. Gonzalez S, Klatt P, Delgado S, et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature. 2006; 440: 702-6.
30. Sideridou M, Zakopoulou R, Evangelou K, et al. Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. J Cell Biol. 2011; 195: 1123-40.
31. Huang X, Huang F, Yang D, et al. Expression of microRNA-122 contributes to apoptosis in H9C2 myocytes. J Cell Mol Med. 2012; 16: 2637-46.
32. Yu N, Huangyang P, Yang X, et al. microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8. J Biol Chem. 2013; 288: 19633-42.
33. Dai DW, Lu Q, Wang LX, et al. Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM. BMC Cancer. 2013; 13: 478.
34. Liu X, Chen Q, Yan J, et al. MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells. Cell Death Dis. 2013; 4: e928.
35. Wang X, Ling C, Bai Y, et al. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec. 2011; 294: 88-92.